Novavax (NVAX) Tops Q1 EPS by 18c; offers guidance
Tweet
Share
E-mail
Get Alerts NVAX Hot Sheet
Price: $9.13 -3.89%
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
DTGI, CRMT, MAYS, More
EPS Growth %: -164.5%
Financial Fact:
Net loss: -66.25M
Today's EPS Names:
DTGI, CRMT, MAYS, More
Join SI Premium – FREE
Novavax (NASDAQ: NVAX) reported Q1 EPS of ($0.06), $0.18 better than the analyst estimate of ($0.24). Revenue for the quarter came in at $139.51 million versus the consensus estimate of $79.31 million.
GUIDANCE:
Novavax sees FY2026 revenue of $230-270 million, versus the consensus of $394.3 million.
For earnings history and earnings-related data on Novavax (NVAX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Kalshi in early talks for IPO - The Information
- Wall Street scrambles to lift Micron price targets ahead of earnings
- Neotech Metals closes $3.08M private placement
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
Earnings, Maynard Um, Mark Zuckerberg, ARKSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
